tklite t1_jeg12hb wrote

>The other groups were 5 mg/kg CBD (CBD5), saline solution and 20 mg/kg CBD (CBD20);

Best results were shown in the CBD5 group. For a 75kg woman, that would equate to 375mg per day. At current market prices, that's about $41.25 per day. But, perhaps this is why some studies on consumer grade CBD have shown little to no effect--the dosages they're working with are off by at least a factor of 10.


tklite t1_jdywzmw wrote

Eczema and asthma are inflammatory conditions, pointing that the development of osteoarthritis is also an inflammatory condition. Poorly controlled eczema and asthma that over relies on the use of oral steroids can also lead to osteoarthritis.


tklite t1_j9koveg wrote

I think their data could be confused by the concurrent rise in smartphone ownership and apps like Venmo and Cashapp making cash movements in/out of bank accounts no longer as relevant. How much "cash" enters the Venmo/Cashapp environments and just stays there? You wouldn't see as much banking activity around cash and bank transfers because now whole economies exist outside of those institutions, inside untracked apps.


tklite t1_j4s7mfm wrote

>The results were independent of the education level, occupation, marital status and health of the children’s parents as well as the socio-economic disadvantage in the residential area.

I'd be really interested in seeing how health was controlled for in regards to the oligosaccharide content of the mother's breast milk.

On another note...

> Human milk is an example of this and contains oligosaccharides, known as human milk oligosaccharides (HMOs), which are derived from lactose.[21][22] These oligosaccharides have biological function in the development of the gut flora of infants. Examples include lacto-N-tetraose, lacto-N-neotetraose, and lacto-N-fucopentaose.[21][22] These compounds cannot be digested in the human small intestine, and instead pass through to the large intestine, where they promote the growth of Bifidobacteria, which are beneficial to gut health.[23]

The question then becomes, how do these different bacteria that are promoted by the oligosaccharides in human milk go on to affect the body in regards to allergies and other diseases.

>The human infant gut is relatively sterile up until birth, where it takes up bacteria from its surrounding environment and its mother.[14] The microbiota that makes up the infant gut differs from the adult gut. An infant reaches the adult stage of their microbiome at around 3 years of age, when their microbiome diversity increases, stabilizes, and the infant switches over to solid foods. Breast-fed infants are colonized earlier by Bifidobacterium when compared to babies that are primarily formula-fed.[15] Bifidobacterium is the most common bacteria in the infant gut microbiome.[16] There is more variability in genotypes over time in infants, making them less stable compared to the adult Bifidobacterium. Infants and children under 3 years old show low diversity in microbiome bacteria, but more diversity between individuals when compared to adults.[17] Reduction of Bifidobacterium and increase in diversity of the infant gut microbiome occurs with less breast-milk intake and increase of solid food intake. Mammalian milk all contain oligosaccharides showing natural selection[clarification needed]. Human milk oligosaccharides are not digested by enzymes and remain whole through the digestive tract before being broken down in the colon by microbiota. Bifidobacterium species genomes of B. longum, B. bifidum, B. breve contain genes that can hydrolyze some of the human milk oligosaccharides and these are found in higher numbers in infants that are breast-fed. Glycans that are produced by the humans are converted into food and energy for the B. bifidum. showing an example of coevolution.[18]